MediWound Ltd. (MDWD)
12.66
-0.31
(-2.39%)
USD |
NASDAQ |
Aug 26, 14:10
MediWound Enterprise Value : 141.64M for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 141.64M |
| August 24, 2026 | 142.03M |
| August 21, 2026 | 144.74M |
| August 20, 2026 | 143.51M |
| August 19, 2026 | 149.65M |
| August 18, 2026 | 150.29M |
| August 17, 2026 | 147.06M |
| August 14, 2026 | 149.26M |
| August 13, 2026 | 148.87M |
| August 12, 2026 | 153.78M |
| August 11, 2026 | 154.04M |
| August 10, 2026 | 152.75M |
| August 07, 2026 | 159.98M |
| August 06, 2026 | 158.56M |
| August 05, 2026 | 157.39M |
| August 04, 2026 | 158.81M |
| August 03, 2026 | 157.78M |
| July 31, 2026 | 156.49M |
| July 30, 2026 | 156.23M |
| July 29, 2026 | 159.46M |
| July 28, 2026 | 162.94M |
| July 27, 2026 | 160.75M |
| July 24, 2026 | 157.91M |
| July 23, 2026 | 158.43M |
| July 22, 2026 | 160.36M |
| Date | Value |
|---|---|
| July 21, 2026 | 158.56M |
| July 20, 2026 | 162.69M |
| July 17, 2026 | 162.82M |
| July 16, 2026 | 162.82M |
| July 15, 2026 | 157.26M |
| July 14, 2026 | 158.17M |
| July 13, 2026 | 158.17M |
| July 10, 2026 | 158.68M |
| July 09, 2026 | 164.11M |
| July 08, 2026 | 163.98M |
| July 07, 2026 | 167.08M |
| July 06, 2026 | 163.20M |
| July 02, 2026 | 169.92M |
| July 01, 2026 | 165.53M |
| June 30, 2026 | 163.98M |
| June 29, 2026 | 158.12M |
| June 26, 2026 | 159.54M |
| June 25, 2026 | 151.83M |
| June 24, 2026 | 155.17M |
| June 23, 2026 | 145.15M |
| June 22, 2026 | 143.74M |
| June 18, 2026 | 147.33M |
| June 17, 2026 | 146.82M |
| June 16, 2026 | 142.58M |
| June 15, 2026 | 143.61M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 57.61B |
| RedHill Biopharma Ltd. | -- |
| Purple Biotech Ltd. | -3.359M |
| Sol-Gel Technologies Ltd. | 220.39M |
| PolyPid Ltd. | 98.39M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.392M |
| Revenue (Quarterly) | 3.092M |
| Total Expenses (Quarterly) | 10.48M |
| EPS Diluted (Quarterly) | -0.5737 |
| Gross Profit Margin (Quarterly) | 10.90% |
| Profit Margin (Quarterly) | -239.1% |
| Earnings Yield | -12.67% |
| Normalized Earnings Yield | -12.67 |